# OnCo record pfizer (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pfizer/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pfizer" ;
  schema:name "Pfizer (incl. Seagen)"@en ;
  schema:alternateName "Seagen"@en, "Seagen (Pfizer)"@en, "Seattle Genetics"@en ;
  schema:description "Bought Seagen for $43B to become an ADC leader; also makes Ibrance, Lorbrena, Braftovi, and the first PROTAC."@en ;
  schema:url <https://onco.cc/companies/pfizer/>, <https://www.pfizer.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.pfizer.com> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/tisotumab-vedotin/>, <https://onco.cc/drugs/tucatinib/>, <https://onco.cc/drugs/disitamab-vedotin/>, <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/lorlatinib/>, <https://onco.cc/drugs/encorafenib/>, <https://onco.cc/drugs/talazoparib/>, <https://onco.cc/drugs/vepdegestrant/>, <https://onco.cc/drugs/gemtuzumab-ozogamicin/>, <https://onco.cc/drugs/pf-08634404/>, <https://onco.cc/drugs/pf-07248144/>, <https://onco.cc/drugs/sasanlimab/>, <https://onco.cc/drugs/pf-08046054/>, <https://onco.cc/drugs/utomilumab/>, <https://onco.cc/drugs/ponsegromab/>, <https://onco.cc/drugs/samuraciclib/>, <https://onco.cc/drugs/exemestane/>, <https://onco.cc/drugs/estramustine/>, <https://onco.cc/drugs/dexrazoxane/>, <https://onco.cc/drugs/oprelvekin/> ;
  onco:trials <https://onco.cc/trials/nct06003231/>, <https://onco.cc/trials/nct06012435/>, <https://onco.cc/trials/mountaineer/>, <https://onco.cc/trials/nct04579380/>, <https://onco.cc/trials/nct06758401/>, <https://onco.cc/trials/nct06629779/>, <https://onco.cc/trials/nct07028853/>, <https://onco.cc/trials/nct05623020/>, <https://onco.cc/trials/nct06152575/>, <https://onco.cc/trials/nct05020236/>, <https://onco.cc/trials/nct05317416/>, <https://onco.cc/trials/nct04404283/>, <https://onco.cc/trials/nct04657991/>, <https://onco.cc/trials/nct04430738/>, <https://onco.cc/trials/nct07227012/>, <https://onco.cc/trials/nct03709680/>, <https://onco.cc/trials/nct07476287/>, <https://onco.cc/trials/nct07227415/>, <https://onco.cc/trials/nct04557449/>, <https://onco.cc/trials/nct07227298/>, <https://onco.cc/trials/nct04553133/>, <https://onco.cc/trials/nct04606446/>, <https://onco.cc/trials/nct05217446/>, <https://onco.cc/trials/nct07489066/>, <https://onco.cc/trials/nct06206837/>, <https://onco.cc/trials/nct07475806/>, <https://onco.cc/trials/nct05748171/>, <https://onco.cc/trials/nct07421700/>, <https://onco.cc/trials/nct07566156/>, <https://onco.cc/trials/nct04821622/>, <https://onco.cc/trials/nct04225117/>, <https://onco.cc/trials/nct05548127/>, <https://onco.cc/trials/nct05262400/>, <https://onco.cc/trials/nct05230810/>, <https://onco.cc/trials/nct05909397/>, <https://onco.cc/trials/nct04721977/>, <https://onco.cc/trials/nct05573555/>, <https://onco.cc/trials/nct06966453/>, <https://onco.cc/trials/nct06760637/>, <https://onco.cc/trials/nct00248287/>, <https://onco.cc/trials/nct05226871/> .